Jeffrey Peterson

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. ncbi An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase
    Sean W Deacon
    Basic Sciences Division, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Chem Biol 15:322-31. 2008
  2. ncbi Biochemical suppression of small-molecule inhibitors: a strategy to identify inhibitor targets and signaling pathway components
    Jeffrey R Peterson
    Division of Basic Sciences, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, USA
    Chem Biol 13:443-52. 2006
  3. ncbi Specificity profiling of Pak kinases allows identification of novel phosphorylation sites
    Ulrike E E Rennefahrt
    Division of Basic Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Biol Chem 282:15667-78. 2007
  4. ncbi Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro
    Henry E Pelish
    Department of Cell Biology and The CBR Institute for Biomedical Research, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Chem Biol 2:39-46. 2006
  5. ncbi Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation
    Jeffrey R Peterson
    Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Struct Mol Biol 11:747-55. 2004
  6. ncbi Geometric diversity through permutation of backbone configuration in cyclic peptide libraries
    Zachary E Perlman
    Department of Systems Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115l, USA
    Bioorg Med Chem Lett 15:5329-34. 2005
  7. ncbi Src transforms in a Cool way
    Jeffrey R Peterson
    Nat Cell Biol 8:905-7. 2006

Collaborators

  • JONATHAN D CHERNOFF
  • MARK A STAMNES
  • Sean W Deacon
  • Ulrike E E Rennefahrt
  • Alexander Beeser
  • Henry E Pelish
  • Zachary E Perlman
  • Jami A Fukui
  • Cynthia Myers
  • Karthik Devarajan
  • Benjamin E Turk
  • Sirlester A Parker
  • Stefan Knapp
  • Ji-Long Chen
  • Tomas Kirchhausen
  • Enrique Rodriguez-Boulan
  • Susana B Salvarezza
  • Yan Feng
  • Eric Macia
  • Matthew D Shair
  • Jonathan E Bock
  • R Scott Lokey

Detail Information

Publications7

  1. ncbi An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase
    Sean W Deacon
    Basic Sciences Division, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Chem Biol 15:322-31. 2008
    ..These studies illustrate an alternative strategy for kinase inhibition and introduce a highly selective, cell-permeable chemical inhibitor of Pak...
  2. ncbi Biochemical suppression of small-molecule inhibitors: a strategy to identify inhibitor targets and signaling pathway components
    Jeffrey R Peterson
    Division of Basic Sciences, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111, USA
    Chem Biol 13:443-52. 2006
    ..This work introduces a general method for using low-micromolar chemical inhibitors to identify both inhibitor targets and other components of a signaling pathway...
  3. ncbi Specificity profiling of Pak kinases allows identification of novel phosphorylation sites
    Ulrike E E Rennefahrt
    Division of Basic Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    J Biol Chem 282:15667-78. 2007
    ..Collectively, these results elucidate the specificity of Pak kinases and illustrate a general method for the identification of novel sites phosphorylated by Paks...
  4. ncbi Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro
    Henry E Pelish
    Department of Cell Biology and The CBR Institute for Biomedical Research, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Chem Biol 2:39-46. 2006
    ..RhoGDI-dependent Cdc42 inhibition by secramine illustrates a new way to inhibit Rho GTPases with small molecules and provides a new means to study Cdc42, RhoGDI and the cellular processes they mediate...
  5. ncbi Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation
    Jeffrey R Peterson
    Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Struct Mol Biol 11:747-55. 2004
    ..The use of small molecules to bias conformational equilibria represents a potentially general strategy for chemical inhibition of autoinhibited proteins, even in cases where such sites have not been naturally evolved in a target...
  6. ncbi Geometric diversity through permutation of backbone configuration in cyclic peptide libraries
    Zachary E Perlman
    Department of Systems Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115l, USA
    Bioorg Med Chem Lett 15:5329-34. 2005
    ..These concepts were applied to the synthesis of cyclodimeric variants of an inhibitor of actin assembly in Xenopus egg extracts, yielding side chain variants with improved potency over the original scaffold...
  7. ncbi Src transforms in a Cool way
    Jeffrey R Peterson
    Nat Cell Biol 8:905-7. 2006

Research Grants6

  1. Allosteric, Small-Molecule Inhibitors of Actin Nucleation by the Formin mDia1
    Jeffrey Peterson; Fiscal Year: 2007
    ..Future work will apply this screen to a much larger compound collection and we envisage applying a similar strategy to develop inhibitors for other formins. ..
  2. Specificity of Effector Activation by Rho Family GTPases
    Jeffrey Peterson; Fiscal Year: 2009
    ..This proposal will illuminate how this coordination could be corrupted in disease and will provide crucial information for the selection of optimal drug targets for new therapeutic approaches. ..
  3. Specificity of Effector Activation by Rho Family GTPases
    Jeffrey R Peterson; Fiscal Year: 2010
    ..This proposal will illuminate how this coordination could be corrupted in disease and will provide crucial information for the selection of optimal drug targets for new therapeutic approaches. ..
  4. Specificity of Effector Activation by Rho Family GTPases
    Jeffrey Peterson; Fiscal Year: 2009
    ..This proposal will illuminate how this coordination could be corrupted in disease and will provide crucial information for the selection of optimal drug targets for new therapeutic approaches. ..